Cylindrospermopsin induced transcriptional responses in human hepatoma HepG2 cells

Toxicology in Vitro

Volumn 27, Issue 6, 2013, Pages 1809-1819

  Štraser, Alja ^a   Filipič, Metka ^a   Žegura, Bojana ^a  

^a NATIONAL INSTITUTE OF BIOLOGY   (Slovenia)

Author keywords

Apoptosis; Cell cycle; Cylindrospermopsin; Detoxification response; DNA damage repair; Immediate early response

Indexed keywords

ALDEHYDE DEHYDROGENASE; CHECKPOINT KINASE 1; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; CYLINDROSPERMOPSIN; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A6; GLUTATHIONE TRANSFERASE M3; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN C JUN; PROTEIN FOS; PROTEIN P53; XERODERMA PIGMENTOSUM GROUP C PROTEIN;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE ARREST; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL STRESS; CELL SURVIVAL; CONTROLLED STUDY; DETOXIFICATION; DNA DAMAGE; DNA REPAIR; EXCISION REPAIR; EXPOSURE; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOME ANALYSIS; GENOTOXICITY; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; METABOLISM; MULTIGENE FAMILY; SIGNAL TRANSDUCTION; TOXICOGENETICS; UPREGULATION;

EID: 84879402450     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2013.05.012     Document Type: Article

References (110)

1. Amundson S.A., Patterson A., Do K.T., Fornace A.J. A nucleotide excision repair master-switch: p53 regulated coordinate induction of global genomic repair genes. Cancer Biol. Ther. 2002, 1:145-149.
2. Arita K., Ariyoshi M., Tochio H., Nakamura Y., Shirakawa M. Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism. Nature 2008, 455:818-821.
3. Arner E.S.J., Holmgren A. The thioredoxin system in cancer. Semin. Cancer Biol. 2006, 16:420-426.
4. Bain P., Shaw G., Patel B. Induction of p53-regulated gene expression in human cell lines exposed to the cyanobacterial toxin cylindrospermopsin. J. Toxicol. Environ. Health: A 2007, 70:1687-1693.
5. Bazin E., Huet S., Jarry G., Hegarat L.L., Munday J.S., Humpage A.R., Fessard V. Cytotoxic and genotoxic effects of cylindrospermopsin in mice treated by gavage or intraperitoneal injection. Environ Toxicol 2010.
6. Bazin E., Mourot A., Humpage A.R., Fessard V. Genotoxicity of a freshwater cyanotoxin, cylindrospermopsin, in two human cell lines: Caco-2 and HepaRG. Environ. Mol. Mutagen. 2010, 51:251-259.
7. Bruhat A., Jousse C.l, Wang X.-Z., Ron D., Ferrara M., Fafournoux P. Amino acid limitation induces expression of CHOP, a CCAAT/enhancer binding protein-related gene, at both transcriptional and post-transcriptional levels. J. Biol. Chem. 1997, 272:17588-17593.
8. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 1999, 96:857-868.
9. Cam H., Dynlacht B.D. Emerging roles for E2F: beyond the G1/S transition and DNA replication. Cancer Cell 2003, 3:311-316.
10. Carlson S.G., Fawcett T.W., Bartlett J.D., Bernier M., Holbrook N.J. Regulation of the C/EBP-related gene gadd153 by glucose deprivation. Mol. Cell. Biol. 1993, 13:4736-4744.
11. Carmichael W.W., Azevedo S.M., An J.S., Molica R.J., Jochimsen E.M., Lau S., Rinehart K.L., Shaw G.R., Eaglesham G.K. Human fatalities from cyanobacteria: chemical and biological evidence for cyanotoxins. Environ. Health Perspect. 2001, 109:663-668.
12. Chen Q., Yu K., Holbrook N.J., Stevens J.L. Activation of the growth arrest and DNA damage-inducible gene gadd 153 by nephrotoxic cysteine conjugates and dithiothreitol. J. Biol. Chem. 1992, 267:8207-8212.
13. Chong M.W.K., Wong B.S.F., Lam P.K.S., Shaw G.R., Seawright A.A. Toxicity and uptake mechanism of cylindrospermopsin and lophyrotomin in primary rat hepatocytes. Toxicon 2002, 40:205-211.
14. Christmann M., Tomicic M.T., Roos W.P., Kaina B. Mechanisms of human DNA repair: an update. Toxicology 2003, 193:3-34.
15. Dasika G.K., Lin S.C., Zhao S., Sung P., Tomkinson A., Lee E.Y. DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene 1999, 18:7883-7899.
16. Dickinson D.A., Warnes G.R., Quievryn G., Messer J., Zhitkovich A., Rubitski E., Aubrecht J. Differentiation of DNA reactive and non-reactive genotoxic mechanisms using gene expression profile analysis. Mutat. Res./Fundam. Mol. Mech Mutagen. 2004, 549:29-41.
17. Dijkers P.F., Medema R.H., Lammers J.-W.J., Koenderman L., Coffer P.J. Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr. Biol. 2000, 10:1201-1204.
18. Du C., Fang M., Li Y., Li L., Wang X. Smac, a mitochondrial protein that promotes cytochrome dependent caspase activation by eliminating IAP inhibition. Cell 2000, 102:33-42.
19. Ellinger-Ziegelbauer H., Stuart B., Wahle B., Bomann W., Ahr H.-J. Characteristic expression profiles induced by genotoxic carcinogens in rat liver. Toxicol. Sci. 2004, 77:19-34.
20. Ellinger-Ziegelbauer H., Stuart B., Wahle B., Bomann W., Ahr H.J. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver. Mutat. Res./Fundam. Mol. Mech Mutagen. 2005, 575:61-84.
21. Ellinger-Ziegelbauer H., Aubrecht J., Kleinjans J.C., Ahr H.-J. Application of toxicogenomics to study mechanisms of genotoxicity and carcinogenicity. Toxicol. Lett. 2009, 186:36-44.
22. EPA, 2010. Creating a Cyanotoxin Target List for the Unregulated Contaminant Monitoring Ruley. US Environmental Protection Agency, Technical Service Center, Cincinnati, OH.
23. Falconer I.R., Humpage A.R. Preliminary evidence for in vivo tumour initiation by oral administration of extracts of the blue-green alga Cylindrospermopsis raciborskii containing the toxin cylindrospermopsin. Environ. Toxicol. 2001, 16:192-195.
24. Falconer I.R., Hardy S.J., Humpage A.R., Froscio S.M., Tozer G.J., Hawkins P.R. Hepatic and renal toxicity of the blue-green alga (cyanobacterium) Cylindrospermopsis raciborskii in male Swiss albino mice. Environ. Toxicol. 1999, 14:143-150.
25. Fessard V., Bernard C. Cell alterations but no DNA strand breaks induced in vitro by cylindrospermopsin in CHO K1 cells. Environ. Toxicol. 2003, 18:353-359.
26. Froscio S.M., Humpage A.R., Burcham P.C., Falconer I.R. Cell-free protein synthesis inhibition assay for the cyanobacterial toxin cylindrospermopsin. Environ. Toxicol. 2001, 16:408-412.
27. Froscio S.M., Humpage A.R., Burcham P.C., Falconer I.R. Cylindrospermopsin-induced protein synthesis inhibition and its dissociation from acute toxicity in mouse hepatocytes. Environ. Toxicol. 2003, 18:243-251.
28. Froscio S.M., Cannon E., Lau H.M., Humpage A.R. Limited uptake of the cyanobacterial toxin cylindrospermopsin by Vero cells. Toxicon 2009, 54:862-868.
29. Gordon E.M., Liu P.X., Chen Z.H., Liu L., Whitley M.D., Gee C., Groshen S., Hinton D.R., Beart R.W., Hall F.L. Inhibition of metastatic tumor growth in nude mice by portal vein infusions of matrix-targeted retroviral vectors bearing a cytocidal cyclin G1 construct. Cancer Res. 2000, 60:3343-3347.
30. Gramantieri L., Ferracin M., Fornari F., Veronese A., Sabbioni S., Liu C.-G., Calin G.A., Giovannini C., Ferrazzi E., Grazi G.L., Croce C.M., Bolondi L., Negrini M. Cyclin G1 is a target of miR-122a, a MicroRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res. 2007, 67:6092-6099.
31. Guedez L., Stetler-Stevenson W.G., Wolff L., Wang J., Fukushima P., Mansoor A., Stetler-Stevenson M. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J. Clin. Investig. 1998, 102:2002-2010.
32. Habraken Y., Piette J. NF-kB activation by double-strand breaks. Biochem. Pharmacol. 2006, 72:1132-1141.
33. Halleck M.M., Holbrook N.J., Skinner J., Liu H., Stevens J.L. The molecular response to reductive stress in LLC-PK1 renal epithelial cells: coordinate transcriptional regulation of gadd153 and grp78 genes by thiols. Cell Stress Chaperon. 1997, 2:31-40.
34. Harbour J.W., Luo R.X., Santi A.D., Postigo A.A., Dean D.C. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 1999, 98:859-869.
35. Hawkins P.R., Runnegar M.T., Jackson A.R., Falconer I.R. Severe hepatotoxicity caused by the tropical cyanobacterium (blue-green alga) Cylindrospermopsis raciborskii (Woloszynska) Seenaya and Subba Raju isolated from a domestic water supply reservoir. Appl. Environ. Microbiol. 1985, 50:1292-1295.
36. Hayakawa T., Yamashita K., Tanzawa K., Uchijima E., Iwata K. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells A possible new growth factor in serum. FEBS Lett. 1992, 298:29-32.
37. Hayashi T., Ueno Y., Okamoto T. Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. J. Biol. Chem. 1993, 268:11380-11388.
38. Heise T., Schug M., Storm D., Ellinger-Ziegelbauer H., Ahr H.J., Hellwig B., Rahnenfuhrer J., Ghallab A., Guenther G., Sisnaiske J., Reif R., Godoy P., Mielke H., Gundert-Remy U., Lampen A., Oberemm A., Hengstler J.G. In vitro - in vivo correlation of gene expression alterations induced by liver carcinogens. Curr. Med. Chem. 2012, 19:1721-1730.
39. Hinson J.A., Forkert P.-G. Phase II enzymes and bioactivation. Can. J. Physiol. Pharmacol. 1995, 73:1407-1413.
40. Hochegger H., Takeda S., Hunt T. Cyclin-dependent kinases and cell-cycle transitions: does one fit all?. Nat. Rev. Mol. Cell Biol. 2008, 9:910-916.
41. Holgado-Madruga M., Wong A.J. Role of the Grb2-associated binder 1/SHP-2 interaction in cell growth and transformation. Cancer Res. 2004, 64:2007-2015.
42. Holgado-Madruga M., Emlet D.R., Moscatello D.K., Godwin A.K., Wong A.J. A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 1996, 379:560-564.
43. Holgado-Madruga M., Moscatello D.K., Emlet D.R., Dieterich R., Wong A.J. Grb2-associated binder-1 mediates phosphatidylinositol 3-kinase activation and the promotion of cell survival by nerve growth factor. Proc. Nat. Acad. Sci. 1997, 94:12419-12424.
44. Hollander M.C., Fornace A.J. Induction of fos RNA by DNA-damaging agents. Cancer Res. 1989, 49:1687-1692.
45. Humpage A.R., Falconer I.R. Oral toxicity of the cyanobacterial toxin cylindrospermopsin in male Swiss albino mice: determination of no observed adverse effect level for deriving a drinking water guideline value. Environ. Toxicol. 2003, 18:94-103.
46. Humpage A.R., Fenech M., Thomas P., Falconer I.R. Micronucleus induction and chromosome loss in transformed human white cells indicate clastogenic and aneugenic action of the cyanobacterial toxin, cylindrospermopsin. Mutat. Res./Genet. Toxicol. Environ. Mutagen. 2000, 472:155-161.
47. Humpage A., Fontaine F., Froscio S., Burcham P., Falconer I. Cylindrospermopsin genotoxicity and cytotoxicity: role of cytochrome P-450 and oxidative stress. J. Toxicol. Environ. Health: A 2005, 68:739-753.
48. Janssens S., Tschopp J. Signals from within: the DNA-damage-induced NF-[kappa]B response. Cell Death Differ. 2006, 13:773-784.
49. Jiang Y., Goldberg I.D., Shi Y.E. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 2002, 21:2245-2252.
50. Ke S., Rabson A.B., Germino J.F., Gallo M.A., Tian Y. Mechanism of suppression of cytochrome P-450 1A1 expression by tumor necrosis factor-α and lipopolysaccharide. J. Biol. Chem. 2001, 276:39638-39644.
51. Kelman Z., O'Donnell M. Dna polymerase III holoenzyme: structure and function of a chromosomal replicating machine. Annu. Rev. Biochem. 1995, 64:171-200.
52. Kimberley F.C., Screaton G.R. Following a TRAIL: update on a ligand and its five receptors. Cell Res. 2004, 14:359-372.
53. Klefstrom J., Arighi E., Littlewood T., Jaattela M., Saksela E., Evan G.I., Alitalo K. Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-[kappa]B activation. EMBO J. 1997, 16:7382-7392.
54. Knasmüller S., Mersch-Sundermann V., Kevekordes S., Darroudi F., Huber W.W., Hoelzl C., Bichler J., Majer B.J. Use of human-derived liver cell lines for the detection of environmental and dietary genotoxicants; current state of knowledge. Toxicology 2004, 198:315-328.
55. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 1997, 3:614-620.
56. Lankoff A., Wojcik A., Lisowska H., Bialczyk J., Dziga D., Carmichael W.W. No induction of structural chromosomal aberrations in cylindrospermopsin-treated CHO-K1 cells without and with metabolic activation. Toxicon 2007, 50:1105-1115.
57. Larochelle S., Merrick K.A., Terret M.-E., Wohlbold L., Barboza N.M., Zhang C., Shokat K.M., Jallepalli P.V., Fisher R.P. Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells. Mol. Cell 2007, 25:839-850.
58. Liang B.C., Miller L., Weller A. Ethyl-nitrosourea transformed astrocytes exhibit mitochondrial membrane hyperpolarization and constrained apoptosis. Apoptosis 1999, 4:89-97.
59. Liebermann D.A., Hoffman B. MyD genes in negative growth control. Oncogene 1998, 17:3319-3329.
60. Luethy J.D., Holbrook N.J. Activation of the gadd153 promoter by genotoxic agents: a rapid and specific response to DNA damage. Cancer Res. 1992, 52:5-10.
61. Maga G., Hübscher U. Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J. Cell Sci. 2003, 116:3051-3060.
62. Malumbres M., Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 2009, 9:153-166.
63. Maser R.S., Monsen K.J., Nelms B.E., Petrini J.H. HMre11 and hRad50 nuclear foci are induced during the normal cellular response to DNA double-strand breaks. Mol. Cell. Biol. 1997, 17:6087-6096.
64. McCullough K.D., Martindale J.L., Klotz L.-O., Aw T.-Y., Holbrook N.J. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol. Cell. Biol. 2001, 21:1249-1259.
65. Michael D., Oren M. The p53 and Mdm2 families in cancer. Curr. Opin. Genet. Dev. 2002, 12:53-59.
66. Modur V., Nagarajan R., Evers B.M., Milbrandt J. FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. J. Biol. Chem. 2002, 277:47928-47937.
67. Morgan E.T. Regulation of cytochrome P450 by inflammatory mediators: why and how?. Drug Metab. Dispos. 2001, 29:207-212.
68. Norbury C.J., Hickson I.D. Cellular responses to DNA damage. Annu. Rev. Pharmacol. Toxicol. 2001, 41:367-401.
69. Norris R.L.G., Seawright A.A., Shaw G.R., Senogles P., Eaglesham G.K., Smith M.J., Chiswell R.K., Moore M.R. Hepatic xenobiotic metabolism of cylindrospermopsin in vivo in the mouse. Toxicon 2002, 40:471-476.
70. Osada M., Park H.L., Park M.J., Liu J.-W., Wu G., Trink B., Sidransky D. A p53-type response element in the GDF15 promoter confers high specificity for p53 activation. Biochem. Biophys. Res. Commun. 2007, 354:913-918.
71. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18:6853-6866.
72. Palombo F., Iaccarino I., Nakajima E., Ikejima M., Shimada T., Jiricny J. HMutSβ, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA. Curr. Biol. 1996, 6:1181-1184.
73. Parrilla-Castellar E.R., Arlander S.J.H., Karnitz L. Dial 9-1-1 for DNA damage: the Rad9-Hus1-Rad1 (9-1-1) clamp complex. DNA Repair (Amst) 2004, 3:1009-1014.
74. Podlutsky A.J., Dianova I.I., Podust V.N., Bohr V.A., Dianov G.L. Human DNA polymerase [beta] initiates DNA synthesis during long-patch repair of reduced AP sites in DNA. EMBO J. 2001, 20:1477-1482.
75. Price B.D., Calderwood S.K. Gadd45 and Gadd153 messenger RNA levels are increased during hypoxia and after exposure of cells to agents which elevate the levels of the glucose-regulated proteins. Cancer Res. 1992, 52:3814-3817.
76. Ranuncolo S.M., Polo J.M., Melnick A. BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells. Blood Cells Mol. Dis. 2008, 41:95-99.
77. Reelfs O., Tyrrell R.M., Pourzand C. Ultraviolet a radiation-induced immediate iron release is a key modulator of the activation of NF-[kappa]B in human skin fibroblasts. J. Invest. Dermatol. 2004, 122:1440-1447.
78. Riddick D.S., Lee C., Bhathena A., Timsit Y.E. The 2001 Veylien Henderson award of the Society of Toxicology of Canada. Positive and negative transcriptional regulation of cytochromes P450 by polycyclic aromatic hydrocarbons. Can. J. Physiol. Pharmacol. 2003, 81:59-77.
79. Riddick D.S., Lee C., Bhathena A., Timsit Y.E., Cheng P.-Y., Morgan E.T., Prough R.A., Ripp S.L., Miller K.K.M., Jahan A., Chiang J.Y.L. Transcriptional suppression of cytochrome P450 genes by endogenous and exogenous chemicals. Drug Metab. Dispos. 2004, 32:367-375.
80. Roberts A.B. Molecular and cell biology of TGF-β. Miner. Electrolyte Metab. 1998, 24:111-119.
81. Roberts A.B., Sporn M.B. Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors 1993, 8:1-9.
82. Runnegar M.T., Kong S.-M., Zhong Y.-Z., Lu S.C. Inhibition of reduced glutathione synthesis by cyanobacterial alkaloid cylindrospermopsin in cultured rat hepatocytes. Biochem. Pharmacol. 1995, 49:219-225.
83. Runnegar M.T., Xie C., Snider B.B., Wallace G.A., Weinreb S.M., Kuhlenkamp J. In vitro hepatotoxicity of the cyanobacterial alkaloid cylindrospermopsin and related synthetic analogues. Toxicol. Sci. 2002, 67:81-87.
84. Rushmore T.H., Tony Kong A.N. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr. Drug Metab. 2002, 3:481-490.
85. Schilter B., Turesky R.J., Juillerat M., Honegger P., Guigoz Y. Phase I and phase II xenobiotic reactions and metabolism of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in aggregating liver cell cultures. Biochem. Pharmacol. 1993, 45:1087-1096.
86. Serrano M., Hannon G.J., Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993, 366:704-707.
87. Sharif J., Muto M., Takebayashi S.-i., Suetake I., Iwamatsu A., Endo T.A., Shinga J., Mizutani-Koseki Y., Toyoda T., Okamura K., Tajima S., Mitsuya K., Okano M., Koseki H. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 2007, 450:908-912.
88. Shaw G.R., Seawright A.A., Moore M.R., Lam P.K.S. Cylindrospermopsin, a cyanobacterial alkaloid: evaluation of its toxicological activity. Ther. Drug Monit. 2000, 22:89-92.
89. Shen X., Lam P.K.S., Shaw G.R., Wickramasinghe W. Genotoxicity investigation of a cyanobacterial toxin, cylindrospermopsin. Toxicon 2002, 40:1499-1501.
90. Sherman M.L., Datta R., Hallahan D.E., Weichselbaum R.R., Kufe D.W. Ionizing radiation regulates expression of the c-jun protooncogene. Proc. Nat. Acad. Sci. 1990, 87:5663-5666.
91. Song M.-K., Yoon J.-S., Song M., Choi H.-S., Shin C.-Y., Kim Y.-J., Ryu W.-I., Lee H.-S., Ryu J.-C. Gene expression analysis identifies DNA damage-related markers of benzo[a]pyrene exposure in HepG2 human hepatocytes. Toxicol. Environ. Health Sci. 2012, 4:19-29.
92. Štraser A., Filipič M., Žegura B. Genotoxic effects of the cyanobacterial hepatotoxin cylindrospermopsin in the HepG2 cell line. Arch. Toxicol. 2011, 85:1617-1626.
93. Terao K., Ohmori S., Igarashi K., Ohtani I., Watanabe M.F., Harada K.I., Ito E., Watanabe M. Electron microscopic studies on experimental poisoning in mice induced by cylindrospermopsin isolated from blue-green alga Umezakia natans. Toxicon 1994, 32:833-843.
94. Thybaud V., Le Fevre A.-C., Boitier E. Application of toxicogenomics to genetic toxicology risk assessment. Environ. Mol. Mutagen. 2007, 48:369-379.
95. Ueno M., Masutani H., Arai R.J., Yamauchi A., Hirota K., Sakai T., Inamoto T., Yamaoka Y., Yodoi J., Nikaido T. Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J. Biol. Chem. 1999, 274:35809-35815.
96. Unoki M., Brunet J., Mousli M. Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis. Biochem. Pharmacol. 2009, 78:1279-1288.
97. Vairapandi M., Balliet A.G., Hoffman B., Liebermann D.A. GADD45b and GADD45g are cdc2/cyclin B1 kinase inhibitors with a role in S and G2/M cell cycle checkpoints induced by genotoxic stress. J. Cell. Physiol. 2002, 192:327-338.
98. Van Antwerp D.J., Martin S.J., Verma I.M., Green D.R. Inhibition of TNF-induced apoptosis by NF-κB. Trends Cell Biol. 1998, 8:107-111.
99. Verhagen A.M., Ekert P.G., Pakusch M., Silke J., Connolly L.M., Reid G.E., Moritz R.L., Simpson R.J., Vaux D.L. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 2000, 102:43-53.
100. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature 2000, 408:307-310.
101. Wang Q.-e., Zhu Q., Wani M.A., Wani G., Chen J., Wani A.A. Tumor suppressor p53 dependent recruitment of nucleotide excision repair factors XPC and TFIIH to DNA damage. DNA Repair (Amst) 2003, 2:483-499.
102. Webster G.A., Perkins N.D. Transcriptional cross talk between NF-κB and p53. Mol. Cell. Biol. 1999, 19:3485-3495.
103. Weidner K.M., Di Cesare S., Sachs M., Brinkmann V., Behrens J., Birchmeier W. Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature 1996, 384:173-176.
104. Welch, J.N., Chrylogelos, S.A., 2002. Positive mediators of cell proliferation in neoplastic transformation, In: G.J. Tsongalis, W.B.C.a. (Ed.), The Molecular Basis of Human Cancer. Humana Press, New Jersey, USA, pp. 65-79.
105. Yang G., Zhang G., Pittelkow M.R., Ramoni M., Tsao H. Expression profiling of UVB response in melanocytes identifies a set of p53-target genes. J. Invest. Dermatol. 2006, 126:2490-2506.
106. Youle R.J., Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008, 9:47-59.
107. Žegura B., Gajski G., Štraser A., Garaj-Vrhovac V. Cylindrospermopsin induced DNA damage and alteration in the expression of genes involved in the response to DNA damage, apoptosis and oxidative stress. Toxicon 2011, 58:471-479.
108. Žegura B., Štraser A., Filipič M. Genotoxicity and potential carcinogenicity of cyanobacterial toxins - a review. Mutat. Res./Rev. Mutat. Res. 2011, 727:16-41.
109. Zhan Q., Antinore M.J., Wang X.W., Carrier F., Smith M.L., Harris C.C., Fornace A.J. Association with Cdc2 and inhibition of Cdc2/cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene 1999, 18:2892-2900.
110. Zhou B.B., Elledge S.J. The DNA damage response: putting checkpoints in perspective. Nature 2000, 408:433-439.